Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who have been newly diagnosed with triple negative breast cancer (a specific type of breast cancer) and whose doctor has recommended a particular type of chemotherapy (called ATC-based chemotherapy) either before or after surgery
- People aged between 18 and 75 years
- People who have signed a written consent form agreeing to take part
- People with a body mass index (a measure of body weight relative to height) of 19 or above
Who may not be able to join:
- People who are allergic to any ingredients in the diet being studied in the trial
- People with a known history of heart problems
- People with serious health conditions that prevent them from receiving cancer treatment
- People who are currently taking part in another clinical trial that involves an active treatment (trials that only collect data or biological samples are not affected by this rule)
- People who are pregnant
- People who have previously been treated with a type of chemotherapy drug called an anthracycline
- People whose breast cancer tests positive for estrogen receptors (confirm with trial site if unsure what this means for a specific diagnosis)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Franny Jongbloed, MD/PhD, Erasmus Medical Center
Phone: +31639462883
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
High-sensitivity troponin T (hsTnT)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.